Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma

Diagnostic Molecular Pathology

Volumn 9, Issue 1, 2000, Pages 1-8

  Antonescu, Cristina R ^a   Kawai, Akira ^a   Leung, Denis H ^a   Lonardo, Fulvio ^a   Woodruff, James M ^a   Healey, John H ^a   Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; BAX; BCL2; Ki 67; Proliferation; Soft tissue; TUNEL

Indexed keywords

KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE ASSOCIATION; GENE FUSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYNOVIAL SARCOMA;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIFFERENTIATION; DNA PRIMERS; EPITHELIUM; HUMANS; IN SITU NICK-END LABELING; KI-67 ANTIGEN; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034008724     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200003000-00001     Document Type: Article

References (44)

1. Antonescu CR, Leung DH, Dudas M, et al. Alterations of cell cycle regulators in localized synovial sarcoma. A mutlifactorial study with prognostic implications. Am J Pathol (in press).
2. Argani P, Zakowski MF, Klimstra DS, Rosai J, Ladanyi M. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol 1998;11:65-71.
3. Brett D, Whitehouse S, Per A, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 1997;6:1559-64.
4. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
5. Chand A, Clark J, Cooper CS, Craig IW. Long-range organization of reiterated sequences, including the SSX1 CDNA at the OATL1 cluster in Xp11.23. Genomics 1995;30:545-52.
6. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395-419.
7. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-8.
8. Crew AJ, Clark J, Fisher C, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the kruppel-associated box in human synovial sarcoma. EMBO J 1995;14: 2333-40.
9. De Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum Mol Genet 1995;4:1097-9.
10. De Leeuw B, Suijkerbuijk RF, Olde Weghuis D, et al. Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genet Cytogenet 1994;73:89-94.
11. DeLellis RA, Kwan P. Technical considerations in the immunohistochemical demonstration of intermediate filaments. Am J Surg Pathol 1988;12(suppl 1):17-23.
12. dos Santos NR, de Bruijn DRH, Balemans M, et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet 1997;6:1549-58.
13. Enzinger FM, Weiss SW, eds. Soft Tissue Tumors, 3d ed. St. Louis, MO: Mosby, 1995:29:757-86.
14. Fisher C. Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors. Hum Pathol 1986;17:996-1008.
15. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol 1995; 147:1592-9.
16. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22:673-82.
17. Frisch SM. The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 1997;19:705-9.
18. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
19. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990;1:199-206.
20. Gure AO, Tureci O, Sahin U, et al. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997;72:965-71.
21. Hiraga H, Nojima T, Abe S, et al. Diagnosis of synovial sarcoma with reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors. Diagn Mol Pathol 1998;7:102-10.
22. Hirakawa N, Naka T, Yamamoto I, Fukuda T, Tsuneyoshi M. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol 1996;27:1060-5.
23. Janz M, De Leeuw B, Olde Weghuis D, et al. Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J Pathol 1995;175:391-6.
24. Jensen V, Sorensen FB, Bentzen SM, et al. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas. Histopathology 1998;32: 536-46.
25. Jorgensen LJ, Lyon H, Myhre-Jensen O, Nordentoft A, Sneppen O. Synovial sarcoma. An immunohistochemical study of the epithelial component. APMIS 1994;102:191-6.
26. Kashima T, Matsushita H, Kuroda M, et al. Biphasic synovial sarcoma of the peritoneal cavity with t(X; 18) demonstrated by reverse transcriptase polymerase chain reaction. Pathol Int 1997; 47:637-41.
27. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998;338:153-60.
28. Kerr JF, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994;73:2013-26.
29. Le Brun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993;142: 743-53.
30. Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC. A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 1998;17:2013-8.
31. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simoes M, Nesland JM. Proliferative activity of synovial sarcoma: an immunohistochemical evaluation of Ki-67 labeling indices of 52 primary and recurrent tumors. Ultrastruct Pathol 1995;19:101-6.
32. Miettinen M, Sarlomo-Rikala M, Kovatich AJ. Cell-type-and tumour-type-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch 1998;433:255-60.
33. Nilsson G, Skytting B, Xie Y, et al. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999;59:3180-4.
34. Ordonez NG, Mahfouz SM, Mackay B. Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol 1990; 21:733-19.
35. Pilotti S, Mezzelani A, Azzarelli A, Rilke F, Pierotti MA. bcl-2 expression in synovial sarcoma. J Pathol 1998;184:337-9.
36. Renwick PJ, Reeves BR, Dal Cin P, et al. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2. with implications for the histologic sub-classification of synovial sarcoma. Cytogenet Cell Genet 1995;70: 58-63.
37. Shipley J, Crew J, Birdsall S, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol 1996;148: 559-67.
38. Shipley JM, Clark J, Crew AJ, et al. The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome. Oncogene 1994;9:1447-53.
39. Skytting B, Nilsson G, Brodin B, et al. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst 1999;91: 974-5.
40. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RSK. Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 1994;144: 1121-34.
41. Staunton MJ, Gaffney EF. Apoptosis: basic concepts and potential significance in human cancer. Arch Pathol Lab Med 1998;122: 310-9.
42. Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol 1998; 22:863-72.
43. Tsuji S, Hisaoka M, Morimitsu Y, et al. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol 1998;153:1807-12.
44. van de Rijn M, Barr FG, Collins MH, Xiong Q-B, Fisher C. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. Am J Clin Pathol 1999;112:43-9.